Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis Congenita
Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Sharon A. Savage(National Cancer Institute), E. Anders Kolb(Nemours Children's Health System), H. Joachim Deeg(Fred Hutch Cancer Center), Gèrard Socié(Hôpital Saint-Louis), Éric Deconinck(European Union), Frederick D. Goldman(University of Alabama at Birmingham), José Sánchez de Toledo Codina(Hospital Materno-Infantil), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Reuven Or(Hadassah Academic College), Alok Srivastava(M.J.P. Rohilkhand University), Kirsten M. Williams(National Institutes of Health), Carmem Sales‐Bonfim(Hospital de Clínicas Universidade Federal do Paraná), Mary Eapen(Medical College of Wisconsin), Blanche P. Alter(National Institutes of Health), Joseph H. Antin(Dana-Farber Cancer Institute), Jeanette Carreras(Medical College of Wisconsin), Joanne Kurtzberg(Duke University), Jakub Tolar(University of Minnesota System), Wing Leung(KK Women's and Children's Hospital), Shalini Shenoy(St. Louis Children's Hospital), Anders Fasth(University of Gothenburg), Robert A. Krance(Baylor College of Medicine), Mouhab Ayas(King Faisal Specialist Hospital & Research Centre), Neelam Giri(National Institutes of Health Clinical Center), Philip S. Rosenberg(Department of Health and Human Services), Ardeshir Ghavamzadeh(Tehran University of Medical Sciences), Jeffrey Davis(BC Children's Hospital), Reggie Duerst(Lurie Children's Hospital), Carol M. Richman(University of California, Davis), Prasad Bodhi(Rainbow Babies & Children's Hospital)
Cited by 130
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k